Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by MabVax Therapeutics, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
MabVax Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01141491
First received: June 9, 2010
Last updated: February 1, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)